Cargando…
A Response to: Letter to the Editor Regarding “Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: a Narrative Review”
Autores principales: | Hilleman, Daniel E., Wiggins, Barbara S., Bottorff, Michael B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444398/ https://www.ncbi.nlm.nih.gov/pubmed/32647913 http://dx.doi.org/10.1007/s12325-020-01420-z |
Ejemplares similares
-
Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review
por: Hilleman, Daniel E., et al.
Publicado: (2020) -
Letter to the Editor Regarding Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review
por: Bannenberg, Gerard, et al.
Publicado: (2020) -
Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products
por: Fialkow, Jonathan
Publicado: (2016) -
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
por: Backes, James, et al.
Publicado: (2016) -
Letter to Editor Regarding the OCEAN Study [Letter]
por: Yawn, Barbara P, et al.
Publicado: (2021)